EUVIMEDEUVIMED entdecken
Crossref

L26/P-392 From Prediction to Decision: Patient Choices Following AI-Based Non-Invasive Oocyte Assessment in Elective Fertility Preservation

M.I. Riqueros Arevalo, M. Bellés Fernandez, M. Suarez de la Rosa, J.M. Molina Sabater, E. Palmeiro Prieto, R. Picón Manjón, L. Murria Aguilar, M. Meseguer Escrivá, M. Esbert Algam, M. Florensa Bargallo

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.726 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M.I. Riqueros Arevalo und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question How is patient decision-making regarding additional oocyte vitrification cycles associated with AI-based predictive information from non-invasive oocyte markers and physician’s recommendation? Summary answer Patient decisions following AI-based oocyte competence assessment were associated with predicted reproductive outcomes, with a substantial proportion discontinuing further vitrification cycles despite clinical recommendations. What is known already Social fertility preservation is rapidly increasing worldwide, yet counselling remains largely based on female age and the number of vitrified oocytes. Decisions regarding additional cycles must be made immediately, as deferring until oocyte warming may occur years later, when ovarian reserve has declined and further preservation may no longer be feasible. Recent advances in automated oocyte morphology analysis have enabled quantitative estimation of blastocyst formation and live birth probability from static images of mature oocytes. However, to our knowledge, no studies have assessed whether integrating individualized prognostic information into clinical counselling influences patient decision-making or treatment trajectories in fertility preservation. Study design, size, duration This retrospective observational study was conducted at a university affiliated reproductive medicine center and included 139 women undergoing their first elective oocyte vitrification cycle. Patient decisions to proceed or discontinue vitrification after receiving AI-based oocyte competence predictions were analysed. All eligible cycles performed between January and December 2025 were included. Participants/materials, setting, methods Patients undergoing elective social fertility preservation received an AI-based assessment of mature oocytes following ovarian stimulation. Individualized reports provided predicted probabilities of achieving ≥1 blastocyst and at least 1 and 2 live births (LB). Patient decisions during post-procedure consultations were recorded and analysed in relation to clinical recommendations and AI-predicted outcomes. Appropriate parametric tests were used, with Bonferroni correction for multiple comparisons. Main results and the role of chance Mean patient age was 35.68±2.86 years, and 13.76±8.90 MII oocytes were vitrified per cycle. After receiving the AI-based oocyte competence report, 57.55% (n = 80) discontinued further cycles, while 42.45% (n = 59) pursued additional fertility preservation cycles. Overall, patients who continued treatment showed poorer ovarian reserve than those who stopped, with lower AMH (1.35±1.15 vs. 2.92±2.89, p < 0.001), lower antral follicle count (10.89±7.09 vs. 15.42±8.42, p < 0.005), and fewer MII oocytes (6.15±4.21 vs. 13.09±6.97, p < 0.001), while age was similar (35.81±3.10 vs. 35.59±2.69) Three decision patterns were observed after AI report disclosure and physician counselling: agreement to stop (Group I, n = 37), agreement to continue (Group II, n = 59), and disagreement, in which patients declined further cycles despite recommendation to continue (Group III, n = 43). No patient pursued additional cycles against medical advice. Patients agreeing to stop had higher AI-predicted probabilities after thawing than those agreeing to continue: ≥1 blastocyst (94.89±0.66 vs. 79.97±18.61, p < 0.001), ≥1 LB (76.43±14.68 vs. 36.66±19.66, p < 0.001), and ≥2 LB (45.78±21.48 vs. 10.95±10.83, p < 0.001) In patients who declined further vitrification cycles despite physician recommendations, predicted probabilities were higher for achieving ≥1 live birth (49.60±17.03 vs. 36.66±19.66, p < 0.001) and ≥1 blastocyst (92.12±7.17 vs. 79.97±18.61, p < 0.001) compared with those who followed physician advice, with no differences regarding ≥2 LB (16.81±11.59 vs 10.95±10.83). Limitations, reasons for caution The retrospective design limits causal interpretation of the relationship between AI-based predictions and patient decision-making. Decisions were assessed after result disclosure and may have been influenced by concurrent clinical counselling or individual patient factors not captured in the analysis. Wider implications of the findings To our knowledge, this is the first study showing that individualised AI-based oocyte competence assessment is associated with patient decision-making in elective fertility preservation. These findings suggest a potential role for AI-derived predictions in supporting autonomous, patient-centred decisions and avoiding unnecessary additional vitrification cycles. Trial registration number No

Zitieren

APA

Arevalo, M. R., Fernandez, M. B., Rosa, M. S. D. L., Sabater, J. M., Prieto, E. P., Manjón, R. P., Aguilar, L. M., Escrivá, M. M., Algam, M. E., & Bargallo, M. F. (2026). L26/P-392 From Prediction to Decision: Patient Choices Following AI-Based Non-Invasive Oocyte Assessment in Elective Fertility Preservation. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.726

Vancouver

Arevalo MR, Fernandez MB, Rosa MSDL, Sabater JM, Prieto EP, Manjón RP, et al. L26/P-392 From Prediction to Decision: Patient Choices Following AI-Based Non-Invasive Oocyte Assessment in Elective Fertility Preservation. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.726

BibTeX
@article{Arevalo2026,
  author = {Arevalo, M.I. Riqueros and Fernandez, M. Bellés and Rosa, M. Suarez de la and Sabater, J.M. Molina and Prieto, E. Palmeiro and Manjón, R. Picón and Aguilar, L. Murria and Escrivá, M. Meseguer and Algam, M. Esbert and Bargallo, M. Florensa},
  title = {L26/P-392 From Prediction to Decision: Patient Choices Following AI-Based Non-Invasive Oocyte Assessment in Elective Fertility Preservation},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.726}
}
Kostenlos starten →